AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
slide-0
slide-1

Glimibrit M 2mg/500mg Tablet SR

Prescription Icon
Prescription Required

Marketer

Elbrit Life Sciences

Salt Composition

Glimepiride (2mg) + Metformin (500mg)

Overview Glimibrit M 2mg/500mg Tablet SR

Diabex Duo 2mg/500mg Extended-Release Tablets are classified as antidiabetic medications. This dual-action formulation treats type 2 diabetes in adults by managing blood glucose levels. Diabex Duo should be ingested with food, consistently at the same time daily for optimal efficacy. Dosage is determined and adjusted by your physician based on your blood sugar response. Continuous use is crucial; discontinuation without medical supervision can lead to elevated blood sugar, potentially resulting in kidney complications, vision impairment, neuropathy, and limb loss. Remember, this medication is part of a comprehensive treatment plan incorporating a balanced diet, regular exercise, and weight management as directed by your doctor. Lifestyle choices are integral to diabetes control. Hypoglycemia (low blood sugar) is a frequent adverse effect. Learn to recognize symptoms like sweating, dizziness, headaches, and tremors, and know how to manage them. Consistent meals and carrying readily available glucose (e.g., sugary snacks, juice) are essential. Alcohol consumption increases hypoglycemia risk and should be limited. Other potential side effects include altered taste, nausea, diarrhea, abdominal discomfort, headaches, and upper respiratory infections. Weight gain may occur. This medication is contraindicated in type 1 diabetes, diabetic ketoacidosis, and severe hepatic or renal impairment. Individuals with a history of heart disease should inform their doctor before starting treatment. Pregnant or lactating women should seek medical counsel prior to use. Regular blood glucose monitoring is necessary, along with potential blood tests to assess blood cell counts and liver function.

Uses of Glimibrit M 2mg/500mg Tablet SR

Managing type 2 diabetes

Major Benefits of Glimibrit M 2mg/500mg Tablet SR:

Consume this medication precisely as directed by your physician, adhering to both the prescribed dosage and treatment length. Ingest the entire tablet without chewing, crushing, or fracturing it. The Glimibrit M 2mg/500mg Sustained-Release tablet should be taken with a meal.

Common Side effects of Glimibrit M 2mg/500mg Tablet SR:

  • Headache
  • Hypoglycemia (low blood glucose level)
  • Nausea
  • Diarrhea

How to use Glimibrit M 2mg/500mg Tablet SR:

Administer this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment schedule. Ingest the entire tablet without chewing, crushing, or breaking it. Consume Glimibrit M 2mg/500mg Extended-Release tablets with food.

How Glimibrit M 2mg/500mg Tablet SR works:

Glimibrit M SR tablets (2mg/500mg) combine glimepiride and metformin, two distinct antidiabetic agents. Glimepiride, a sulfonylurea, stimulates pancreatic insulin secretion, thus reducing blood sugar levels. Metformin, a biguanide, acts by decreasing hepatic glucose production, retarding intestinal glucose uptake, and enhancing insulin responsiveness.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Consuming alcohol alongside Glimibrit M 2mg/500mg SR tablets is inadvisable.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Glimibrit M 2mg/500mg SR tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a developing fetus. A physician will assess the potential advantages against any risks prior to prescribing. Seek medical advice before using this medication.

Breast feedingBreast feedingUNSAFE

Extended-release Glimibrit M 2mg/500mg tablets are contraindicated for breastfeeding mothers. Evidence indicates potential infant toxicity from this medication.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.

KidneyKidneyCAUTION

Patients with kidney impairment should exercise caution when using Glimibrit M 2mg/500mg SR tablets, as dose modification may be necessary. Consult your physician for guidance. In cases of severe kidney disease, Glimibrit M 2mg/500mg SR tablets are contraindicated. Routine monitoring of renal function is recommended during treatment.

LiverLiverCAUTION

Individuals with liver impairment should use Glimibrit M 2mg/500mg Tablet SR cautiously, potentially requiring dosage modification. A physician's consultation is advised. For those with mild to moderate liver disease, initiation should be at a low dose; the medication is contraindicated in patients with severe liver dysfunction.

What if you forget to take Glimibrit M 2mg/500mg Tablet SR :

Should you forget to take your Glimibrit M 2mg/500mg SR Tablet, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosage regimen. Avoid taking a double dose.

Facts to Know About Glimibrit M 2mg/500mg Tablet SR

LabelValue
Developing Habits No.
Treatment Category Diabetes Management

FAQs on Glimibrit M 2mg/500mg Tablet SR

Store this medication in its original, tightly closed container, following the storage instructions on the label. Dispose of any unused medication properly and ensure it's inaccessible to children, pets, and others.
Glimibrit M 2mg/500mg Tablet SR can cause lactic acidosis, a serious medical emergency involving excessive blood lactic acid (also known as MALA, or Metformin-associated lactic acidosis). This rare but potentially harmful side effect is more likely in patients with kidney disease, older adults, or those who consume significant amounts of alcohol. Symptoms include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and a slow heart rate. Seek immediate medical attention and discontinue Glimibrit M if you experience these symptoms.
Glimibrit M 2mg/500mg SR tablets combine glimepiride and metformin to manage type 2 diabetes mellitus in adults. This combination improves blood sugar control when used with diet and exercise. Glimepiride stimulates insulin release from the pancreas, while metformin reduces liver glucose production and enhances insulin sensitivity. It's not suitable for type 1 diabetes.
Glimibrit M 2mg/500mg SR Tablets may cause common side effects including low blood sugar (hypoglycemia), altered taste, nausea, stomach pain, diarrhea, and headache. Rare but serious side effects such as lactic acidosis are also possible. Prolonged use may result in vitamin B12 deficiency.
Prolonged use of Glimibrit M 2mg/500mg SR tablets can lead to vitamin B12 deficiency by hindering its absorption. This deficiency, if left untreated, may result in anemia, neurological issues such as tingling, numbness in extremities, weakness, urinary problems, cognitive changes, and ataxia. To mitigate this risk, supplemental vitamin B12 is recommended annually by some researchers.
Glimibrit M 2mg/500mg SR tablets can cause low blood sugar (hypoglycemia), manifesting as nausea, headache, irritability, hunger, sweating, dizziness, rapid heartbeat, anxiety, or shakiness. This risk increases with missed meals, alcohol consumption, excessive exercise, or concurrent use of other antidiabetic medications. Regular blood sugar monitoring is crucial. Carry a fast-acting sugar source, such as glucose tablets, honey, or fruit juice, at all times.
Combining Glimibrit M 2mg/500mg SR tablets with alcohol is unsafe. Alcohol can exacerbate the drug's effect, potentially causing dangerously low blood sugar (hypoglycemia) and increasing the risk of lactic acidosis.
Glimibrit M 2mg/500mg Tab...
123
MRP 150
18% off